Monobactams--structure-activity relationships leading to SQ 26,776. 1981

H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
October 1984, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
May 2003, Angewandte Chemie (International ed. in English),
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
H Breuer, and C M Cimarusti, and T Denzel, and W H Koster, and W A Slusarchyk, and U D Treuner
December 1981, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!